An OCRA research team is using Artificial Intelligence (AI) to develop a blood test to potentially detect ovarian cancer, as part of an OCRA-funded study in partnership with Microsoft AI … Continued
Livnat Jerby, PhD, is Assistant Professor in the Department of Genetics at Stanford University and a 2022 recipient of OCRA’s Early Career Investigator Grant. Through her OCRA-funded project, she is utilizing cutting-edge … Continued
Ovarian Cancer Research Alliance (OCRA), the world’s largest ovarian cancer charity, announced today the 2023 winners of the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research and the Schreiber … Continued
Dr. Jasmine Plummer of St. Jude Children’s Research Hospital (formerly of Cedars-Sinai Medical Center) is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on better understanding … Continued
In an interview for the podcast Overlooked, OCRA’s President & CEO Audra Moran talked about the future of ovarian cancer research, and how Ovarian Cancer Research Alliance is harnessing the … Continued
Dr. Maria Victoria Botuyan of Mayo Clinic Rochester is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded research is focused on studying how several proteins function together … Continued
We took meaningful steps in the fight against ovarian and related gynecologic cancers this year, and we couldn’t have done it without your support. Join me for a look at … Continued
Snap Summary: OCRA-funded researchers discovered a potential key to reducing chemotherapy resistance, and reducing recurrence rates for the most common type of ovarian cancer. A research team at Magee-Women’s Research … Continued
Snap Summary: New findings could help develop better immune therapy for patients with the most common and lethal subtype of ovarian cancer. A recent study co-authored by Dr. Sherry Wu … Continued
OCRA Announces Game-Changing Initiatives This month, OCRA announced a trio of initiatives that carry profound implications for ovarian cancer and related research and patient support: OCRA will expand its mission to include … Continued
Snap Summary: Research co-funded by OCRA found that foregoing genetic counseling before and after genetic testing does not negatively impact individuals who do not have a pathogenic mutation. Studies have … Continued
Snap Summary: An OCRA-funded study sought to understand why certain ovarian cancer cells resist olaparib treatment, and discovered that introducing a second drug (mifepristone) while targeting certain cells (polyploid giant … Continued
Get email updates about research news, action alerts, and ways to join the fight.
